Barikind 4 mg Tablet

Barikind 4 mg Tablet – Baricitinib 4 mg by Mankind

Barikind 4 mg Tablet, distributed by Mankind Pharma and manufactured by BDR Pharmaceuticals, contains Baricitinib 4 mg in a film-coated tablet. Baricitinib belongs to the newest class of arthritis medicines, the JAK inhibitors. Older disease-modifying drugs work slowly and broadly; biologics work precisely but must be injected. Baricitinib sits between the two – it targets the Janus kinase enzymes JAK1 and JAK2 that carry inflammatory signals from the cell surface to the nucleus, and it does so from an ordinary once-daily tablet. Blocking that relay quietens the swelling, pain and stiffness of rheumatoid arthritis and slows the joint erosion behind it. Bottle of 14 tablets. Specialist prescription medicine.

Key Features

• Baricitinib 4 mg – film-coated tablet, as printed on the pack
• JAK1 and JAK2 inhibitor – targeted synthetic DMARD
• Once-daily oral dosing, no injections
• Manufactured by BDR Pharmaceuticals, distributed by Mankind Pharma
• Bottle of 14 tablets

Composition

• Baricitinib – 4 mg per film-coated tablet
• Excipients – q.s.
• Colours – Ferric Oxide Red USP-NF and Titanium Dioxide IP

Composition as printed on the pack. Refer to the package insert for the complete list of excipients.

Uses & Benefits

• Reduces joint pain, swelling and morning stiffness in rheumatoid arthritis
• Slows the joint damage that untreated inflammatory arthritis causes
• An oral option for patients who have not responded to methotrexate or to injectable biologics
• Taken once daily as a tablet – no injections or infusions
• Also prescribed by specialists for severe alopecia areata and severe atopic dermatitis
• Works within weeks rather than months for many patients

Directions for Use

• Take exactly as prescribed by your specialist – the dose is set for you and is often reduced in kidney impairment
• Swallow the tablet whole with water; do not chew, crush or break it
• May be taken with or without food, at the same time each day
• Do not stop or restart on your own – stopping suddenly can let the disease flare
• Keep every blood-test appointment your doctor books; this medicine is monitored, not simply dispensed

Precautions

• Baricitinib suppresses the immune system. Serious infections – including tuberculosis, shingles and hepatitis B reactivation – can occur. Your doctor will screen you for TB and hepatitis before you start
• Tell your doctor immediately about fever, cough, weight loss, night sweats or a painful blistering rash, and stop the tablet until you are assessed
• Regular blood tests are required – blood counts, liver enzymes and cholesterol are all monitored during treatment
• There is a raised risk of blood clots in the legs and lungs. Report leg swelling or pain, breathlessness or chest pain urgently
• JAK inhibitors carry warnings about major cardiac events and certain cancers, particularly in older smokers – your doctor weighs this before prescribing
• Not for use in pregnancy; effective contraception is needed during treatment and for a week after. Avoid breastfeeding
• Do not take live vaccines while on treatment. Tell your doctor about kidney or liver disease and every other medicine you take

Storage

• Store below 30°C, protected from moisture and direct light
• Keep the tablets in their original container
• Keep out of reach of children

Disclaimer

Prescription medicine – to be sold by retail on the prescription of a specialist only. This information is for general awareness and is not a substitute for professional medical advice, diagnosis or treatment. Baricitinib requires screening before treatment and regular blood-test monitoring during it.